TEVA logo

TEVA

Profile

Full Name

Teva Pharmaceutical Industries Limited

Ticker Symbol

TEVA

Exchange

NYSE

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

Israel

IPO

February 16, 1982

Indexes

Not included

Website

http://www.tevapharm.com

Employees

33892

Key Details

Price

$14.80

Market Cap

Last Dividend

$0.09

TTM Dividend Yield

-

Annual Revenue

$16.54B(+4.41% YoY)

Annual EPS

-$1.45(-190.00% YoY)

PE Ratio

-

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$14.80
TEVA price is $14.80

Price All-time High

$72.00
TEVA price is currently -79.44% below its historical high of $72.00

Price Today Change

-0.54%
TEVA price is down -0.54% today

Price YTD Change

-33.27%
TEVA price is down -33.27% since January 1st

Price 1-year Change

+5.26%
TEVA price is up +5.26% year-on-year

Price 3-year Change

+57.61%
TEVA price is up +57.61% over the past 3 years

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market Cap

$16.96B
TEVA market capitalization is $16.96 billion

Market Cap 3-year Change

+62.65%
TEVA market capitalization is up +62.65% over the past 3 years

Market Cap All-time High

$61.23B
TEVA market capitalization is currently -72.30% below its historical high of $61.23 billion

Market Cap Sector Rank

95.16%
TEVA market capitalization is higher than 95.16% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1.17%
TEVA shares outstanding is up +1.17% year-on-year

Shares Outstanding 3-Year Change

+3.2%
TEVA shares outstanding is up +3.2% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.62
TEVA beta is 0.62

200-day SMA

$17.76
TEVA price is currently -16.66% below its 200-day simple moving average

50-day SMA

$16.78
TEVA price is currently -11.78% below its 50-day simple moving average

RSI

33.53
TEVA 14-day relative strength index is 33.53

Volume

0.70
TEVA 30-day relative volume is 0.70

ATR

$0.55
TEVA average true range is $0.55

10-day Historical Volatility

25.21%
TEVA 10-day historical volatility is 25.21%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.09
TEVA last dividend was $0.09 per share, with an ex-dividend date of November 27, 2017

Next Dividend

-
TEVA next dividend has not yet been announced

Dividend per share

Dividend Per Share

-
TEVA annual dividend per share value is unknown

Dividend per share Sector Rank

-
TEVA annual dividend per share is unknown

Dividend per share 1-Year Change

-
TEVA annual dividend per share 1-year change is unknown

Dividend per share 3-Year Change

-
TEVA annual dividend per share 3-year change is unknown

Dividend yield

Dividend Yield

-
TEVA annual dividend yield value is unknown

Dividend yield Sector Rank

-
TEVA annual dividend yield is unknown

Other

Payout Ratio

-
TEVA annual payout ratio value is unknown

Dividends Paid

-
TEVA annual dividends paid value is unknown

Free Cash Flow

$749.00M
TEVA annual free cash flow is $749.00 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$16.54B
TEVA annual revenue is $16.54 billion

Revenue Analysts Estimate

$17.21B
TEVA annual revenue is currently -3.88% lower than the consensus analysts' forecast

Revenue 1-year Change

+4.41%
TEVA annual revenue is up +4.41% year-on-year

Revenue Sector Rank

96.01%
TEVA annual revenue is higher than 96.01% of companies in Healthcare sector

EPS

EPS

-$1.45
TEVA annual earnings per share is -$1.45

EPS Analysts Estimate

$2.55
TEVA annual earnings per share is currently -156.76% lower than the consensus analysts' forecast

EPS 1-year Change

-190%
TEVA annual earnings per share is down -190% year-on-year

EPS Sector Rank

46.49%
TEVA annual earnings per share is higher than 46.49% of companies in Healthcare sector

Profit

Gross Profit

$8.06B
TEVA annual gross profit is $8.06 billion

Gross Margin

48.74%
TEVA annual gross profit margin is 48.74%

Operating Profit

$3.36B
TEVA annual operating income is $3.36 billion

Operating Margin

20.33%
TEVA annual operating profit margin is 20.33%

Net Income

-$1.64B
TEVA annual net profit is -$1.64 billion

Net Margin

-9.91%
TEVA annual net profit margin is -9.91%

Expenses

Total Expenses

$13.18B
TEVA annual total expenses is $13.18 billion

Operating Expenses

$4.70B
TEVA annual total operating expenses is $4.70 billion

Cost Of Goods Sold

$8.48B
TEVA annual cost of goods sold is $8.48 billion

Selling, General & Administrative Expenses

$3.70B
TEVA annual SGA is $3.70 billion

Depreciation And Amortization

$1.06B
TEVA annual depreciation & amortization is $1.06 billion

Interest Expense

$1.00B
TEVA annual interest expense is $1.00 billion

Income Tax

$676.00M
TEVA annual income tax is $676.00 million

EBIT & EBITDA

EBIT

-$369.00M
TEVA annual earnings before interest & taxes is -$369.00 million

EBITDA

$690.00M
TEVA annual EBITDA is $690.00 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total Assets

$39.33B
TEVA annual total assets is $39.33 billion

Non Current Assets

$26.77B
TEVA annual long term assets is $26.77 billion

Current Assets

$12.55B
TEVA annual total current assets is $12.55 billion

Cash And Cash Equivalents

$3.30B
TEVA annual cash & cash equivalents is $3.30 billion

Accounts Receivable

$3.06B
TEVA annual accounts receivable is $3.06 billion

Inventory

$3.01B
TEVA annual inventory is $3.01 billion

Liabilities

Total Liabilities

$33.61B
TEVA annual total liabilities is $33.61 billion

Long Term Liabilities

$20.81B
TEVA annual total long term liabilities is $20.81 billion

Current Liabilities

$12.80B
TEVA annual total current liabilities is $12.80 billion

Accounts Payable

$2.20B
TEVA annual accounts payable is $2.20 billion

Debt

Total Debt

$18.08B
TEVA annual total debt is $18.08 billion

Total Debt 1-year Change

-10.29%
TEVA annual total debt is down -10.29% year-on-year

Long Term Debt

$16.30B
TEVA annual long term debt is $16.30 billion

Short Term Debt

$1.78B
TEVA annual short term debt is $1.78 billion

Equity & Capital

Shareholders Equity

$5.37B
TEVA annual stockholders equity is $5.37 billion

Book Value

$5.37B
TEVA annual book value is $5.37 billion

Retained Earnings

-$15.17B
TEVA annual retained earnings is -$15.17 billion

Working Capital

-$244.00M
TEVA annual working capital is -$244.00 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash From Operations

$1.25B
TEVA annual cash flow from operations is $1.25 billion

Cash From Operations 1-year Change

-8.85%
TEVA annual cash flow from operations is down -8.85% year-on-year

Cash From Investing

$792.00M
TEVA annual cash flow from investing activities is $792.00 million

Cash From Investing 1-year Change

-18.18%
TEVA annual cash flow from investing activities is down -18.18% year-on-year

Cash From Financing

-$1.79B
TEVA annual cash flow from financing activities is -$1.79 billion

Cash From Financing 1-year Change

+6.38%
TEVA annual cash flow from financing activities is up +6.38% year-on-year

CAPEX

CAPEX

$498.00M
TEVA annual capital expenditures is $498.00 million

CAPEX 1-year Change

-5.32%
TEVA annual capital expenditures is down -5.32% year-on-year

Free Cash Flow

Free Cash Flow

$749.00M
TEVA annual free cash flow is $749.00 million

Free Cash Flow 1-year Change

-11.05%
TEVA annual free cash flow is down -11.05% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross Margin

48.74%
TEVA annual gross profit margin is 48.74%

Operating Margin

20.33%
TEVA annual operating profit margin is 20.33%

Net Margin

-9.91%
TEVA annual net profit margin is -9.91%

ROA & ROE

ROA

-3.96%
TEVA annual return on assets is -3.96%

ROE

-23.67%
TEVA annual return on equity is -23.67%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
TEVA price to earnings ratio value is unknown

PE Ratio Sector Rank

-
TEVA price to earnings ratio is unknown

PB Ratio

PB Ratio

3.16
TEVA price to book ratio is 3.16

PB Ratio Sector Rank

73.65%
TEVA price to book ratio is higher than 73.65% of companies in Healthcare sector

PS Ratio

PS Ratio

1.03
TEVA price to sales ratio is 1.03

PS Ratio Sector Rank

27.53%
TEVA price to sales ratio is higher than 27.53% of companies in Healthcare sector

Enterprise value

Enterprise Value

$31.74B
TEVA enterprise value is $31.74 billion

Enterprise Value Sector Rank

96.36%
TEVA enterprise value is higher than 96.36% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

41.65
TEVA EV/EBITDA is 41.65

EV/EBITDA Sector Rank

96.16%
TEVA EV/EBITDA is higher than 96.16% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current Ratio

0.98
TEVA annual current ratio is 0.98

Quick Ratio

0.75
TEVA annual quick ratio is 0.75

Leverage

Debt To Equity

3.31
TEVA annual debt to equity ratio is 3.31

Interest Coverage Ratio

-0.37
TEVA annual interest coverage ratio is -0.37

Risk & Stability

Piotroski F-Score

4
TEVA piotroski f-score is 4

Altman Z-Score

0.14
TEVA altman z-score is 0.14

Analyst ratings

Recent major analysts updates

Mar 6, 25 B of A Securities
Buy
Jan 30, 25 UBS
Buy
Jan 30, 25 Barclays
Overweight
Jan 23, 25 UBS
Buy
Jan 17, 25 Piper Sandler
Overweight
Dec 18, 24 Barclays
Overweight
Oct 23, 24 Barclays
Overweight
Oct 21, 24 JP Morgan
Neutral
Sep 3, 24 UBS
Buy
Aug 1, 24 Barclays
Overweight

Institutional Ownership

Similar stocks

PODD logo
Insulet (PODD)
BAX logo
Baxter International (BAX)
DGX logo
Quest Diagnostics Incorporated (DGX)
WST logo
West Pharmaceutical Services (WST)
COO logo
Cooper Companies (COO)
NTRA logo
Natera (NTRA)
BIIB logo
Biogen (BIIB)
FMS logo
Fresenius Medical Care AG & Co KGaA (FMS)
LH logo
Laboratory Corporation of America Holdings (LH)
  • What is the ticker symbol for Teva Pharmaceutical Industries Limited?
  • Does Teva Pharmaceutical Industries Limited pay dividends?
  • What sector is Teva Pharmaceutical Industries Limited in?
  • What industry is Teva Pharmaceutical Industries Limited in?
  • What country is Teva Pharmaceutical Industries Limited based in?
  • When did Teva Pharmaceutical Industries Limited go public?
  • Is Teva Pharmaceutical Industries Limited in the S&P 500?
  • Is Teva Pharmaceutical Industries Limited in the NASDAQ 100?
  • Is Teva Pharmaceutical Industries Limited in the Dow Jones?
  • When was Teva Pharmaceutical Industries Limited's last earnings report?
  • When does Teva Pharmaceutical Industries Limited report earnings?
  • Should I buy Teva Pharmaceutical Industries Limited stock now?

What is the ticker symbol for Teva Pharmaceutical Industries Limited?

The ticker symbol for Teva Pharmaceutical Industries Limited is NYSE:TEVA

Does Teva Pharmaceutical Industries Limited pay dividends?

No, Teva Pharmaceutical Industries Limited does not pay dividends

What sector is Teva Pharmaceutical Industries Limited in?

Teva Pharmaceutical Industries Limited is in the Healthcare sector

What industry is Teva Pharmaceutical Industries Limited in?

Teva Pharmaceutical Industries Limited is in the Drug Manufacturers - Specialty & Generic industry

What country is Teva Pharmaceutical Industries Limited based in?

Teva Pharmaceutical Industries Limited is headquartered in Israel

When did Teva Pharmaceutical Industries Limited go public?

Teva Pharmaceutical Industries Limited's initial public offering (IPO) was on February 16, 1982

Is Teva Pharmaceutical Industries Limited in the S&P 500?

No, Teva Pharmaceutical Industries Limited is not included in the S&P 500 index

Is Teva Pharmaceutical Industries Limited in the NASDAQ 100?

No, Teva Pharmaceutical Industries Limited is not included in the NASDAQ 100 index

Is Teva Pharmaceutical Industries Limited in the Dow Jones?

No, Teva Pharmaceutical Industries Limited is not included in the Dow Jones index

When was Teva Pharmaceutical Industries Limited's last earnings report?

Teva Pharmaceutical Industries Limited's most recent earnings report was on Jan 29, 2025

When does Teva Pharmaceutical Industries Limited report earnings?

The next expected earnings date for Teva Pharmaceutical Industries Limited is May 8, 2025

Should I buy Teva Pharmaceutical Industries Limited stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page